瑞普生物(300119.SZ)：拟与专业投资机构共同投资设立并购产业基金

Core Viewpoint - Reap Bio (300119.SZ) aims to enhance its core strategy and expand its business boundaries and industry influence by establishing a partnership with several investment entities to create a new industrial fund focused on key sectors [1] Group 1: Partnership and Fund Establishment - Reap Bio signed a partnership agreement on February 12, 2026, with Haitong M&A (Shanghai) Private Equity Fund Management Co., Ltd., Haitong Kaiyuan Investment Co., Ltd., Gaoyou Industrial Guidance Fund (Limited Partnership), and Tianjin Ruisheng Private Fund Management Co., Ltd. [1] - The partnership will establish the Jiangsu Guotai Haitong Reap M&A Industrial Fund Partnership (Limited Partnership), which will focus on investments in animal health, synthetic biology, pets, and biomedicine [1] Group 2: Financial Commitment - The total subscribed capital for the partnership is set at RMB 1 billion, with Reap Bio contributing RMB 295 million, representing 29.50% of the total subscribed capital [1]